ABSTRACT
INTRODUCTION
In the last two decades, positron emission tomography (PET) has emerged as clinical diagnostic technique, becoming one of the fastest growing imaging tools in modern nuclear medicine (NM). As a result, many hospitals have been interested in developing their imaging services to include PET. Thus, besides the increase in dedicated PET centers (Kearfott et al.,1992) , conventional NM services have been upgraded to perform examinations with radiopharmaceuticals containing positron emitters. However, as conventional NM services are not built for the higher-energy gamma annihilation radiation of such tracers, special attention must be paid in terms of technical and administrative controls to keep radiation exposure as low as reasonably achievable (ALARA principle). In general, radioprotection management is based on the measurement of specific dosimentric quantities. Among them, absorbed dose, i.e. the amount of energy imparted to matter by IR per unit of mass, is the fundamental physical quantity for evaluating potential biological response as a result of exposure to radiation. In SI, the unit of absorbed dose is expressed as the gray (1 Gy = 1 J.kg -1 ) (ICRP, 1991) . To regulate the exposure of workers and the public at large, two derived dose quantities are suggested by ICRP (ICRP, 1991) : equivalent and effective doses, both of which are expressed in sievert (Sv) to distinguish them from absorbed dose in gray (Gy). Effective dose was introduced to represent the long-term risk of harm from radiation exposure, in particular the risk of radioinduced cancer (ICRP, 1991; Amaral, 2005) . In addition to effective dose, other dose limits to the tissues that are most likely to receive high exposure are also recommended such as skin and hands, which are also referred to as extremities (ICRP, 1991) . For individual monitoring of an external radiation source the ambient dose equivalent at depth of 10 mm in soft tissue has been defined as personal dose equivalent (Hp(10)). In order to evaluate weakly penetrating radiation, dose at 0.07 mm in soft tissue (Hp(0.07)) is taken as skin dose, once 70 µm is considered the skin's basal cell layer (ICRU, 1985) . Because 511 keV positron annihilation radiation energy is much higher than the 140 keV of conventional nuclear medicine, medical staff working in PET studies may receive a higher equivalent dose than those working only with conventional nuclear medicine tracers do. This high energy radiation, together with many variables involved in clinical routine such as the availability of shielding, administered activity and throughput of patients, have posed an impact on radiation protection considerations to the technologists working in PET procedures. This has motivated several studies for better perception of the radiation dose levels received by technologists undertaking imaging with positron-emitter tracers (Wu et al., 2000; Roberts et al., 2005; Schleipman et al., 2006; Seierstad et al., 2007) . There are several positron-emitter isotopes employed in PET studies such as Carbon-11, Nitrogen-13, Oxygen-15 and Fluorine-18, which allow many naturally occurring substances to be radiolabelled.
The latter, as the radiopharmaceutical fluorodeoxyglucose ([ 18 F]-FDG), is the most commonly used tracer in the clinical setting (around 90 %). In this context, the aim of this work was to evaluate the radiation doses to technologists from some individual tasks using the [18F]-FDG for PET studies.
MATERIAL AND METHODS

PET Centers
This investigation was carried out in two nuclear medicine (NM) departments in France (A and B), presenting significant differences in their layout and radiation protection conditions, but employing only [
18 F]-FDG in their PET studies.
Dosimeters
For evaluating the whole-body dose (Hp (10)) and skin dose (Hp(0.07)), medical staff was supplied with Siemens electronic semiconductor dosimeter EPD-MK2. To assess extremity dose a Polimaster Geiger Mueller based wristwatch dosimeter PM-1603 was employed, which being light, as well as small and having a dose sensitivity of 0.1 µSv, was particularly suitable for this investigation (Texier et al., 2001; Sylvain and Bok, 2002 
Individual Monitoring
During each individual task, two semiconductor EPD dosimeters were worn by medical staff: one for measuring the daily whole-body dose and another for registering each task dose. Each dose value was obtained directly from both dosimeters and recorded at the end of each task. In the two investigated NM centers, the procedure of setting up an intravenous line has been performed prior to administering the tracer to patient. Besides the monitoring of daily whole-body dose received by technologists working in two centers, the following tasks concerning PET procedures were investigated: 1-Drawing up of tracer; 2-Injecting the tracer; 3-Removal of intravenous lines. The wrist dose was recorded by the wristwatch dosimeter only for the tasks 1 and 2. The procedure called "removal of intravenous lines" took into account the whole time spent by the technologist accompanying the patient through entire sequence of this task.
RESULTS
A total number of 180 whole body PET studies were carried out in this work. The two NM centers administered activities, in MBq, of 306 ± 35 (Center A) and 303 ± 26 (Center B) per patient of 70 kg. 
DISCUSSION
It has been observed that the radiation doses to technologist working in PET studies are generally higher than for conventional nuclear medicine (Clarke et al., 1992; Harding et al., 1990 , Chiesa et al., 1997 Clarke et al., 1997 FDG drawing up presented similar results for both NM departments, namely about 20 nSv/MBq. Still considering drawing up of tracer, the effective and skin doses were lower in the Center A than in B. This result was associated to the PET-dedicated workstation that is available in the center A. In the center B, the workstation used for this task was not designed to protect the technologist from 511 keV gamma photons. In the task concerning tracer administration to patient the wrist doses were about 7.5 and 15 nSv/MBq, respectively. This twofold difference can be explained by the use of PET Syringe Shield in Center A, but not in center B. This radioprotection condition also explains the values of Hp(10) and Hp(0.07) obtained as a result of radiopharmaceutical injection to patient. One can observe that technologists from center B used to remove intravenous lines, on average, twice as fast as the ones from center A, which explains the lower doses were registered for this task in that center.
The mean daily whole-body dose to technologists working in Center A (10 µSv) was greater than for the Center B (40 µSv). The estimation for monthly whole-body dose was 194 µSv (about 0.19 mSv) for Center A and 325 µSv (~ 0.33 mSv) for the Center B. This can firstly be related to difference in radioprotection conditions. As said before, Center A was built as a dedicated PET Center, while Center B was an adaptation from conventional NM. For example, layout, shielding of the walls and workstation of the Center A were realized to develop only PET procedures. On the other hand, Center B kept the same technical features as conventional NM project and added positron emission tasks to its routine.
Figures 1 through 3 are provided to give an idea of radioprotection conditions of the Center A. Fig. 1 shows the drawing up of [
18 F]-FDG in PET workstation. Fig. 2 presents a technologist wearing the dosimeter EPD-MK2 (pointed out by the arrow) during the transportation of the shielded syringe. Although the Geiger Mueller based wristwatch dosimeter does not appear in this figure was also worn. Fig. 3 shows the instant when the tracer is administered to patient. These figures, taken in the Center A, and the results presented in tables 1 and 2 do not emphasize the principal contribution to the wholebody dose absorbed by technologists is the radiation that comes from the patients. The results presented in this work pointed out the importance of radiation protection conditions for optimization of absorbed doses delivered to technologists in such practices. Besides this, the high sensitivity of electronic dosimeters indicate these devices as being an important tool for dose management, helping to provide a better individual task distribution for workers in PET centers.
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RESUMO
O objetivo deste trabalho foi o de avaliar doses absorvidas por profissionais de saúde em diferentes tarefas relacionadas à tomografia por emissão de pósitrons com [18F]-FDG (fluordesoxiglicose). Esta pesquisa foi realizada em dois centros de medicina nuclear na França, os quais apresentavam diferenças significativas em sua organização e radioproteção. Esses centros aplicavam aproximadamente 300 MBq por exame PET/CT, embora apenas um deles correspondesse a um serviço de medicina nuclear dedicado a exames por PET. A dose equivalente (Hp(10)) e a dose na pele Hp(0,07) foram medidas usando dosímetros eletrônicos (Siemens). Para avaliação da dose nas mãos do tecnologista durante a preparação do radiofármaco e durante injeção no paciente, um dosímetro tipo relógio de pulso (Polimaster) foi empregado. A dose absorvida e o tempo empregado durante cada tarefa foram registrados para um total de 180 exames de corpo inteiro através da PET. Neste trabalho, a metodologia empregada, os resultados e suas conseqüências na dose absorvida para o profissional de saúde são apresentados e discutidos.
